Health-Related Quality of Life with Cervical Cancer and Precancer: A Cross-Sectional Study in Yunnan Province, China
Clinical and Experimental Obstetrics & Gynecology · 02.08.2023 · 50 (8)
DOI: 10.31083/j.ceog5008161 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Clinical and Experimental Obstetrics & Gynecology, online erschienen am 02.08.2023. Verfasst von Min Zhao und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program for Innovative Research Team of Yunnan Province, Major Union Specific Project Foundation of Yunnan Provincial Science and Technology Department and Kunming Medical University, Scientific Research Fund Project of the Yunnan Provincial Department of Education.
Abstract (Originalsprache)
Background
Cervical cancer is the fourth most common cancer in women, with an estimated 600,000 new cases and 340,000 deaths worldwide in 2020. However, there remains limited understanding of the association between individual socioeconomic status, clinical characteristics, and health-related quality of life (HRQoL) of women with cervical precancerous lesions. This study investigates socioeconomic and clinical variations in HRQoL of women with cervical precancerous lesions and cervical cancer in Yunnan Province, China.
Methods
The present study employed a cross-sectional survey design. An EuroQol Five Dimensions Five Level (EQ-5D-5L) questionnaire was used to assess HRQoL of 400 patients with cervical precancerous lesions and cervical cancer in Yunnan Province, China, from 2019 to 2020. Analysis of variance (ANOVA) and independent samples t-tests were performed to identify the independent variables associated with EQ-5D-5L utility scores and visual analogue scale (VAS) scores. Predictors of utility scores were confirmed using a Tobit regression model.
Results
The mean EQ-5D-5L utility scores of cervical precancerous lesions and cervical cancer patients was 0.939 (standard deviation (SD), 0.104), and the mean VAS score was 80.84 (SD, 16.551). Patients aged 40–59 years (β = –0.037, p = 0.005), patients who were not aware of the human papillomavirus (HPV) vaccine (β = –0.032, p = 0.004), and patients who underwent radical hysterectomy (β = –0.036, p = 0.006) had significantly lower utility scores, whereas having high monthly household income (β = 0.023, p = 0.033) was significantly associated with higher EQ-5D-5L utility scores. Age (p = 0.023) was statistically significant in differences in patients’ VAS scores. Anxiety/depression was the most frequently reported issue (35.75%) among participants.
Conclusions
Future cervical cancer prevention and treatment guidelines should focus on low-income women, women aged 40–59 years, and those lacking knowledge about cervical cancer prevention.
Förderung
- Program for Innovative Research Team of Yunnan Province
- Major Union Specific Project Foundation of Yunnan Provincial Science and Technology Department and Kunming Medical University
- Scientific Research Fund Project of the Yunnan Provincial Department of Education
- Research on Precise Prevention and Treatment of Gynecological Tumors and Application Promotion Innovation Team in Yunnan Province
Zitieren
APA
Zhao, M., Zhang, M., He, L., Zuo, C., Ding, S., Golden, A. R., & Cai, L. (2023). Health-Related Quality of Life with Cervical Cancer and Precancer: A Cross-Sectional Study in Yunnan Province, China. Clinical and Experimental Obstetrics & Gynecology, 50(8). https://doi.org/10.31083/j.ceog5008161
Vancouver
Zhao M, Zhang M, He L, Zuo C, Ding S, Golden AR, et al. Health-Related Quality of Life with Cervical Cancer and Precancer: A Cross-Sectional Study in Yunnan Province, China. Clinical and Experimental Obstetrics & Gynecology. 2023;50(8). doi:10.31083/j.ceog5008161
BibTeX
@article{Zhao2023,
author = {Zhao, Min and Zhang, Meng-Jiao and He, Lian-Ju and Zuo, Chun-Mei and Ding, Song-Rui and Golden, Allison Rabkin and Cai, Le},
title = {Health-Related Quality of Life with Cervical Cancer and Precancer: A Cross-Sectional Study in Yunnan Province, China},
journal = {Clinical and Experimental Obstetrics & Gynecology},
year = {2023},
volume = {50},
number = {8},
doi = {10.31083/j.ceog5008161}
}
EUVIMED